Equity research

Coverage for the companies the sell side stopped reading.

A full initiation on your company, and a note after every filing. Published free, and every figure ties to the filing it came from.

See the coverage Ask us to cover a company

The gap

Below a billion dollars, the sell side stops reading.

Coverage follows trading commissions, and a company this size does not generate any.

44%
of small and mid-caps have no analyst at all.
SEC Advocate for Small Business Capital Formation, December 2024
3
analysts on the average microcap. Twenty on an S&P 500 name.
SEC Advocate for Small Business Capital Formation, January 2026
1%
is what a stock loses the day its last analyst drops it.
Kelly and Ljungqvist, New York University, 2011

Independent research

MAGNSpecialty materialsIndependent

Magnera Corporation

Priced as an over-levered spin-off at 5.5x trailing EBITDA. Half the merger savings are banked, and $90M to $110M of free cash flow is going to debt, moving value to shareholders.

Price: $11.63
Market value: $416.4m
Stance: BUY (initiated)

INGNMedical devicesIndependent

Inogen, Inc.

Priced as a declining oxygen-device maker. US unit volume rose by high single digits last quarter while US sales fell, and net cash covers 75% of the market value.

Price: $5.37
Market value: $142.5m
Stance: BUY (initiated)

BOTJCommunity bankingIndependent

Bank of the James Financial Group, Inc.

Priced as a plain Virginia community bank at 10.7x trailing earnings. Return on equity rose to 14.8% from 10.75% a year earlier, and the wealth arm needs almost no capital.

Price: $27.04
Market value: $122.9m
Stance: BUY (initiated)

MPTIElectronic componentsIndependent

M-tron Industries, Inc.

Priced as a defense parts maker that ran too far and diluted holders. Backlog of $84.0m covers most of next year, and $96.2m of cash with no debt funds acquisitions.

Price: $76.73
Market value: $333.4m
Stance: BUY (initiated)

NATRNutritional supplementsIndependent

Nature's Sunshine Products, Inc.

Priced for a broken direct seller at a one-year low. China is 8.5% of sales, gross margin is at a four-year high, and net cash is 27.2% of the market value.

Price: $12.76
Market value: $224.6m
Stance: BUY (initiated)

What a note contains

Six sections, written to one standard.

Five pages. A tear sheet, a boxed thesis, then the six.

The business

What it sells, to whom, and the unit economics under it.

The market

The addressable market, sourced and dated. The peer set, named once.

Financials

Five years back, three forward. As filed, not as presented.

Valuation

Bear, base and bull with probabilities. One twelve-month target.

Risks

Exactly five, ranked by expected cost.

Catalysts

Five to seven, dated, each with the number to watch.

The tear sheet carries float, daily volume, short interest, institutional ownership and insider holding, read from 13F, 13D and 13G filings by CUSIP rather than an aggregator. No analyst is named on a published note; the standard is the firm’s.

How it works

The model finds it. We write it. It stays free.

The model reads the market
Every US-listed company, scored on 49 factors: size and tradeability, profitability, the gap between company value and market value, and who is already watching.
We choose from what it surfaces
Initiations on companies we would want to own. Where we would not, we decline, which is why you will not find a sell rating here.
We read the whole record
Filings, transcripts, the register by CUSIP, and management on every name, every note.
It publishes free
The argument sits on the page for anyone, and the PDF goes to anyone who asks.

Request coverage

Tell us the ticker.

An intake rather than a promise, and somebody reads every one. Asking does not make a company a client, and no amount of money buys a rating.

Research published here is written and published by LALC Capital. Krypton AI, Inc. is a separate company under common control, and where a company pays Krypton AI for investor relations the report on it says so in full at its foot. The analysis is the same on a paying company as on any other. This is for information only. It is not investment advice and not a recommendation to buy or sell any security. Figures are drawn from public filings and may contain errors.